Demographic data of patients with Wegener granulomatosis
Patient no. . | Age, y/ sex . | PR3-ANCA, U/mL . | Organ involvement . | BVAS . |
|---|---|---|---|---|
| 1 | 53/F | 128 | Ear, nose, and throat; lung; kidney; skin; arthralgias/arthritides; constitutional symptoms; peripheral nervous system | 24 |
| 2 | 73/M | 90 | Ear, nose, and throat; lung; kidney; arthralgias/arthritides; constitutional symptoms; peripheral nervous system | 9 |
| 3 | 51/M | 55 | Ear, nose, and throat; lung; eye | 9 |
| 4 | 62/M | 26 | Ear, nose, and throat; lung; peripheral nervous system; constitutional symptoms | 6 |
| 5 | 63/F | 34 | Ear, nose, and throat; lung; peripheral nervous system; constitutional symptoms; heart; eye; arthralgias/arthritides | 0 |
| 6 | 78/M | 0 | Ear, nose, and throat; lung; constitutional symptoms | 13 |
| 7 | 45/M | 16 | Ear, nose, and throat; lung; kidney; eye; skin; Gl system | 10 |
| 8 | 39/M | 12 | Lung; arthralgias/arthritides; heart; peripheral nervous system; constitutional symptoms | 13 |
| 9 | 63/F | 0 | Ear, nose, and throat; kidney; eye; constitutional symptoms | 0 |
| 10 | 37/M | 0 | Ear, nose, and throat; lung; arthralgias/arthritides; skin; constitutional symptoms | 13 |
Patient no. . | Age, y/ sex . | PR3-ANCA, U/mL . | Organ involvement . | BVAS . |
|---|---|---|---|---|
| 1 | 53/F | 128 | Ear, nose, and throat; lung; kidney; skin; arthralgias/arthritides; constitutional symptoms; peripheral nervous system | 24 |
| 2 | 73/M | 90 | Ear, nose, and throat; lung; kidney; arthralgias/arthritides; constitutional symptoms; peripheral nervous system | 9 |
| 3 | 51/M | 55 | Ear, nose, and throat; lung; eye | 9 |
| 4 | 62/M | 26 | Ear, nose, and throat; lung; peripheral nervous system; constitutional symptoms | 6 |
| 5 | 63/F | 34 | Ear, nose, and throat; lung; peripheral nervous system; constitutional symptoms; heart; eye; arthralgias/arthritides | 0 |
| 6 | 78/M | 0 | Ear, nose, and throat; lung; constitutional symptoms | 13 |
| 7 | 45/M | 16 | Ear, nose, and throat; lung; kidney; eye; skin; Gl system | 10 |
| 8 | 39/M | 12 | Lung; arthralgias/arthritides; heart; peripheral nervous system; constitutional symptoms | 13 |
| 9 | 63/F | 0 | Ear, nose, and throat; kidney; eye; constitutional symptoms | 0 |
| 10 | 37/M | 0 | Ear, nose, and throat; lung; arthralgias/arthritides; skin; constitutional symptoms | 13 |
ANCA indicates antineutrophil cytoplasmic antibody; BVAS, Birmingham vasculitis activity score; F, female; and M, male.